Clexane and Meniscal degeneration - a phase IV clinical study of FDA data

Summary:

Meniscal degeneration is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are female, 60+ old, also take Diovan, and have High blood pressure.

The phase IV clinical study analyzes which people have Meniscal degeneration when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Meniscal degeneration?

Meniscal degeneration (loss of function in a crescent-shaped piece of cartilage between the femur and the tibia) is found to be associated with 70 drugs and 85 conditions by eHealthMe. Check the latest studies of Meniscal degeneration.

On Jul, 20, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 13 people (0.09%) have Meniscal degeneration.

Could Clexane cause Meniscal degeneration?

Among these 13 people:

What is the gender of people who have Meniscal degeneration when taking Clexane? *

female: 100 %
male: 0.0 %

What is the age of people who have Meniscal degeneration when taking Clexane? *

What are other drugs people take besides Clexane? *

What are other side effects people have besides Meniscal degeneration? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 13 people, 100.00%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 13 people, 100.00%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 13 people, 100.00%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 13 people, 100.00%
Rashes (redness): 13 people, 100.00%
Nausea And Vomiting: 13 people, 100.00%
Metastases To Lung (cancer spreads to lung): 13 people, 100.00%
Metastases To Central Nervous System (cancer spreads to central nervous system): 13 people, 100.00%
Melanocytic Naevus (a type of lesion that contains nevus cells (a type of melanocyte)): 13 people, 100.00%
Blood Glucose Increased: 13 people, 100.00%

What are the existing conditions these people have? *

High Blood Pressure: 13 people, 100.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 8 people, 61.54%
Rashes (redness): 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Meniscal degeneration?

- Check whether Meniscal degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meniscal degeneration:

Meniscal degeneration (70 drugs)

Browse all the conditions that are associated with Meniscal degeneration:

Meniscal degeneration (85 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.